Introduction
Dragon Pharma EQ 300 is marketed as containing 300 mg/ml of boldenone undecylenate and is presented in a 10-milliliter multidose vial. To validate its label claims and ensure product transparency, AnabolicLab procured samples of EQ 300 and submitted them for independent laboratory analysis.
The analysis, conducted by SIMEC AG, revealed that EQ 300 underdelivered its label claim, containing 229.9 mg/ml of boldenone undecylenate—76.6% of the declared dosage. While the product was free from microbiological contamination, the significant discrepancy in potency raises concerns about its consistency and reliability. The analysis and sample submission were funded by AnabolicLab to promote transparency and harm reduction in the anabolic steroid market.
Product Overview
- Manufacturer: Dragon Pharma
- Product Name: EQ 300
- Active Ingredient: Boldenone Undecylenate
- Batch Number: DPEQ-01
- Expiration Date: May 2019
- Delivery Method: Injectable (10 mL multidose vial, 300 mg/mL)
- Specification: 300 mg/mL boldenone undecylenate (as per label claim)
Sample Acquisition and Testing
- Date Purchased: Between August 1, 2016, and September 15, 2016
- Source: European-based internet supplier
- Product Submitted By: AnabolicLab
- Analysis Paid For By: AnabolicLab
- Analysis Performed By: SIMEC AG
- Date Received by Lab: September 29, 2016
- Date Report Completed: October 31, 2016
Testing Results
- Quantitative Dosage Testing (HPLC-UV):
- Claimed Dosage: 300 mg/mL
- Measured Dosage: 229.9 mg/mL boldenone undecylenate
- Accuracy: 76.6% (significantly below label claim)
- Microbiological Testing (TAMC and TYMC):
- Result: No microbiological contamination detected
Summary
Dragon Pharma EQ 300 was determined to underdeliver its labeled dosage specification, containing only 229.9 mg/ml boldenone undecylenate compared to the declared 300 mg/ml. While the product was free from microbiological contamination, its reduced potency raises significant concerns about quality and reliability. By funding the analysis and submitting the samples, AnabolicLab emphasizes the importance of independent testing to ensure transparency and harm reduction in the anabolic steroid market.
Disclaimer: The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.
Discuss the Dragon Pharma EQ 300 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
